Summary:
- The article discusses concerns raised by the Advisory Committee on Immunization Practices (ACIP) about the policy of routinely vaccinating newborns against hepatitis B.
- ACIP members acknowledged that the policy was not based on strong scientific evidence, but rather on a "narrative" that the benefits outweighed the risks.
- The article suggests that the policy should be re-evaluated to ensure it is grounded in robust scientific data and not influenced by non-scientific factors.